Notable Labs Pre-Tax Income 2013-2024 | NTBLQ

Notable Labs pre-tax income from 2013 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
Notable Labs Annual Pre-Tax Income
(Millions of US $)
2023 $-11
2022 $-14
2021 $-30
2020 $-24
2019 $-19
2018 $-20
2017 $-10
2016 $-16
2015 $-15
2014 $-17
2013 $-17
2012 $-12
Notable Labs Quarterly Pre-Tax Income
(Millions of US $)
2024-06-30 $-5
2024-03-31 $-4
2023-12-31 $-0
2023-09-30 $-1
2023-06-30 $-3
2023-03-31 $-6
2022-12-31 $15
2022-09-30 $-9
2022-06-30 $-9
2022-03-31 $-10
2021-12-31 $-9
2021-09-30 $-7
2021-06-30 $-8
2021-03-31 $-6
2020-12-31 $-7
2020-09-30 $-6
2020-06-30 $-6
2020-03-31 $-5
2019-12-31 $-6
2019-09-30 $-5
2019-06-30 $-5
2019-03-31 $-4
2018-12-31 $-4
2018-09-30 $-5
2018-06-30 $-4
2018-03-31 $-7
2017-12-31 $6
2017-09-30 $-7
2017-06-30 $-5
2017-03-31 $-5
2016-12-31 $-5
2016-09-30 $-3
2016-06-30 $-3
2016-03-31 $-5
2015-12-31 $-3
2015-09-30 $-6
2015-06-30 $-3
2015-03-31 $-3
2014-12-31 $-5
2014-09-30 $-4
2014-06-30 $-4
2014-03-31 $-5
2013-12-31
2013-09-30
2012-12-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00
Ocuphire Pharma (IRD) $0.000B 0.00